Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J Turner

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Pharmacoeconomics|July 11, 2013
Protease inhibitors for hepatitis C: economic implicationsStuart J Turner, Jack Brown, Joseph A Paladino
Journal of Managed Care & Specialty Pharmacy|April 29, 2016
Treatment Initiation Patterns, Modifications, and Medication Adherence Among Newly Diagnosed Heart Failure Patients: A Retrospective Claims Database AnalysisCéline Deschaseaux, Martin McSharry, Eibhlin Hudson, et al.
International Journal of Antimicrobial Agents|May 21, 2013
Pharmacokinetic/pharmacodynamic evaluation of the efficacy and safety of daptomycin against Staphylococcus aureusRachel L Soon, Stuart J Turner, Alan Forrest, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|April 11, 2013
Pharmacoeconomics of empirical antifungal use in febrile neutropenic hematological malignancy and hematopoietic stem cell transplant patientsStuart J Turner, Sharon C A Chen, Monica A Slavin, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 13, 2015
Effect of chronic urticaria on US patients: analysis of the National Health and Wellness SurveyJeffrey Vietri, Stuart J Turner, Haijun Tian, et al.
BMC Cardiovascular Disorders|May 5, 2018
Signs, symptoms, and treatment patterns across serial ambulatory cardiology visits in patients with heart failure: insights from the NCDR PINNACLE® registryLarry A Allen, Fengming Tang, Philip Jones, et al.
Advances in Therapy|December 10, 2016
Healthcare Costs Among Patients with Heart Failure: A Comparison of Costs between Matched Decedent and Survivor CohortsEngels N Obi, Jason P Swindle, Stuart J Turner, et al.
Journal of Managed Care & Specialty Pharmacy|November 25, 2016
Health Care Costs for Patients with Heart Failure Escalate Nearly 3-Fold in Final Months of LifeEngels N Obi, Jason P Swindle, Stuart J Turner, et al.
COPD|August 6, 2015
Physician-Patient Concordance in Pharmacological Management of Patients with COPDMark Small, Victoria Higgins, Adam Lees, et al.
BMC Infectious Diseases|November 28, 2013
Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in TurkeyStuart J Turner, Esin Senol, Ates Kara, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Pharmacoeconomics|July 11, 2013
Protease inhibitors for hepatitis C: economic implicationsStuart J Turner, Jack Brown, Joseph A Paladino
Journal of Managed Care & Specialty Pharmacy|April 29, 2016
Treatment Initiation Patterns, Modifications, and Medication Adherence Among Newly Diagnosed Heart Failure Patients: A Retrospective Claims Database AnalysisCéline Deschaseaux, Martin McSharry, Eibhlin Hudson, et al.
International Journal of Antimicrobial Agents|May 21, 2013
Pharmacokinetic/pharmacodynamic evaluation of the efficacy and safety of daptomycin against Staphylococcus aureusRachel L Soon, Stuart J Turner, Alan Forrest, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|April 11, 2013
Pharmacoeconomics of empirical antifungal use in febrile neutropenic hematological malignancy and hematopoietic stem cell transplant patientsStuart J Turner, Sharon C A Chen, Monica A Slavin, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 13, 2015
Effect of chronic urticaria on US patients: analysis of the National Health and Wellness SurveyJeffrey Vietri, Stuart J Turner, Haijun Tian, et al.
BMC Cardiovascular Disorders|May 5, 2018
Signs, symptoms, and treatment patterns across serial ambulatory cardiology visits in patients with heart failure: insights from the NCDR PINNACLE® registryLarry A Allen, Fengming Tang, Philip Jones, et al.
Advances in Therapy|December 10, 2016
Healthcare Costs Among Patients with Heart Failure: A Comparison of Costs between Matched Decedent and Survivor CohortsEngels N Obi, Jason P Swindle, Stuart J Turner, et al.
Journal of Managed Care & Specialty Pharmacy|November 25, 2016
Health Care Costs for Patients with Heart Failure Escalate Nearly 3-Fold in Final Months of LifeEngels N Obi, Jason P Swindle, Stuart J Turner, et al.
COPD|August 6, 2015
Physician-Patient Concordance in Pharmacological Management of Patients with COPDMark Small, Victoria Higgins, Adam Lees, et al.
BMC Infectious Diseases|November 28, 2013
Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in TurkeyStuart J Turner, Esin Senol, Ates Kara, et al.
Pageof 3